title: HOPE-3, SPRINT, VALUE and a meta-analysis of trials in patients with diabetes support treatment of hypertension to a target below 140 mmHg.
authors.affiliation: a Department of Cardiology , University of Oslo, Ullevaal Hospital , Oslo , Norway ;
authors.forename: Sverre E
authors.initials: SE
authors.lastname: Kjeldsen
authors.affiliation: b Department of Medicine , University of Göteborg, Sahlgrenska Academy , Göteborg , Sweden ;
authors.forename: Thomas
authors.initials: T
authors.lastname: Hedner
authors.affiliation: c Department of Hypertension and Diabetology , Medical University of Gdansk , Gdansk , Poland.
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Narkiewicz
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D002986:Clinical Trials as Topic; D048909:Diabetes Complications / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D015201:Meta-Analysis as Topic
chemical_list: D000959:Antihypertensive Agents